Free Trial

Stryker (SYK) Stock Forecast & Price Target

Stryker logo
$325.26 -9.82 (-2.93%)
Closing price 11/6/2026 03:59 PM Eastern
Extended Trading
$327.30 +2.04 (+0.63%)
As of 11/6/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Stryker - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
7
Buy
21

Based on 28 Wall Street analysts who have issued ratings for Stryker in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 28 analysts, 7 have given a hold rating, and 21 have given a buy rating for SYK.

Consensus Price Target

$343.73
5.68% Upside
According to the 28 analysts' twelve-month price targets for Stryker, the average price target is $343.73. The highest price target for SYK is $405.00, while the lowest price target for SYK is $275.00. The average price target represents a forecasted upside of 5.68% from the current price of $325.27.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for SYK and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Stryker and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SYK Analyst Ratings Over Time

TypeCurrent Forecast
11/8/25 to 11/8/26
1 Month Ago
10/9/25 to 10/9/26
3 Months Ago
8/10/25 to 8/10/26
1 Year Ago
11/8/24 to 11/8/25
Strong Buy
0 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
21 Buy rating(s)
21 Buy rating(s)
20 Buy rating(s)
13 Buy rating(s)
Hold
7 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$343.73$363.32$385.08$434.11
Forecasted Upside5.68% Upside31.03% Upside11.60% Upside22.03% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

SYK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SYK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Stryker Stock vs. The Competition

TypeStrykerHealthcare CompaniesBroader Market
Consensus Rating Score
2.75
2.32
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside5.68% Upside113.08% Upside17.15% Upside
News Sentiment Rating
Positive News

See Recent SYK News
Neutral News
Positive News
Report Date
0 Results
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
11/2/2026
Stifel Nicolaus logo
Stifel Nicolaus
4 of 5 stars
Rick Wise
Rick Wise
2 of 5 stars
Lower TargetBuy$330.00 ➝ $325.00+9.58%
11/2/2026 Lower Target$360.00 ➝ $336.00-0.49%
11/2/2026
Truist Financial Corporation logo
Truist Financial
2 of 5 stars
Richard Newitter
2 of 5 stars
Reiterated RatingHold$310.00 ➝ $305.00+0.27%
10/30/2026Reiterated RatingOutperform$317.00 ➝ $309.00+4.49%
10/30/2026Lower TargetOutperform$420.00 ➝ $375.00+26.81%
10/30/2026 DowngradeHold
10/30/2026Reiterated RatingOutperform$370.00 ➝ $323.00+3.82%
10/30/2026Reiterated RatingMarket Outperform
10/30/2026Lower TargetBuy$418.00 ➝ $359.00+15.39%
10/30/2026 Lower Target$385.00 ➝ $334.00-1.07%
Many investors are about to lose everything (Ad)

Twenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a household name. Now he says a similar shift is unfolding in AI infrastructure. Hundreds of billions are pouring into AI data centers, but he warns the builders could get crushed by their own costs while one overlooked sector absorbs the spending.tc pixel

Watch the full Ignition Point broadcast to see his top pick
10/30/2026 Lower TargetHold$315.00 ➝ $275.00-18.54%
10/30/2026Lower TargetOverweight$350.00 ➝ $340.00+16.61%
10/30/2026Lower TargetHold$298.00 ➝ $290.00-0.54%
10/30/2026Lower TargetOverweight$375.00 ➝ $365.00+24.17%
10/30/2026Lower TargetMarket Outperform$400.00 ➝ $390.00+25.36%
10/30/2026Lower TargetBuy$316.00 ➝ $304.00-2.29%
10/30/2026DowngradeBuy ➝ Hold$385.00 ➝ $300.00-3.57%
10/29/2026 Reiterated RatingHold (C)
10/28/2026 Boost Target$335.00 ➝ $355.00+5.15%
10/9/2026Lower TargetOutperform$403.00 ➝ $353.00+4.56%
10/7/2026 Reiterated RatingMarket Perform
9/22/2026 Lower TargetBuy$440.00 ➝ $405.00+19.96%
9/9/2026Lower TargetOverweight$418.00 ➝ $348.00+26.02%
8/13/2026DowngradeOutperform ➝ Peer Perform
8/3/2026Lower TargetBuy$400.00 ➝ $382.00+13.15%
7/31/2026Lower TargetOverweight$420.00 ➝ $390.00+11.95%
7/14/2026 Lower TargetNeutral$363.00 ➝ $339.00+0.44%
7/9/2026 Set Target$350.00 ➝ $370.00+12.96%
3/5/2026 Reiterated RatingOutperform
5/2/2025Boost TargetBuy$405.00 ➝ $456.00+20.75%
12/2/2024 UpgradeEqual Weight ➝ Overweight$370.00 ➝ $445.00+13.48%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 07:00 AM ET.


Should I Buy Stryker Stock? SYK Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, November 5, 2026. Please send any questions or comments about these Stryker pros and cons to contact@marketbeat.com.

Stryker
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Stryker Co.:

  • Stryker Co. recently reported strong financial performance in its most recent quarter, delivering an actual EPS of $3.52 which closely matched the consensus estimate of $3.55, while also achieving a year-over-year revenue growth of 7.6% with actual revenue of $6.52 billion, demonstrating the company's ability to maintain steady growth in the medical technology sector.
  • The stock currently trades at $334.85, which is below the average analyst price target of $355.04, suggesting potential upside for investors as the consensus rating remains a Moderate Buy from twenty-four analysts covering the stock.
  • Institutional interest in Stryker Co. has been robust, with several major funds increasing their positions in the third quarter, such as Rakuten Investment Management Inc. which grew its stake by 10.6% and AIA Group Ltd. which increased its holdings by 230.4%, indicating strong confidence from large investors in the company's future prospects.
  • Stryker Co. maintains a favorable balance sheet with a debt-to-equity ratio of 0.60 and a current ratio of 2.18, which provides financial stability and the ability to manage obligations effectively, reducing the risk of financial distress for shareholders.
  • The company offers a dividend yield of 1.15%, providing a modest income stream for investors, which can be attractive for those seeking a combination of growth and income in their healthcare portfolio.

Stryker
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Stryker Co. for these reasons:

  • Recent analyst actions have been negative, with Rothschild & Co Redburn lowering its price target from $360.00 to $336.00 and Truist Financial reducing its target to $305.00, reflecting a cautious outlook on the stock's near-term valuation and potential for further downside.
  • Insider selling has been significant, with Director Ronda E Stryker selling a total of 350,000 shares in August 2026 and other insiders like Dylan Bram Crotty and Debra King also selling shares, which may signal a lack of confidence from those with the most knowledge of the company's internal operations.
  • The stock has experienced volatility and recently crossed below its 50-day moving average, hitting a 52-week low of $267.00 earlier in the year, indicating that the stock has faced significant downward pressure and may still be in a corrective phase.
  • Stryker Co. has a relatively high P/E ratio of 35.66, which suggests that the stock is priced at a premium compared to its earnings, potentially leaving little room for error if future earnings growth does not meet the high expectations set by the market.
  • Short interest in the stock has been notable, with 5.7 million shares shorted as of the latest record date, representing about 1.56% of the float, which indicates that a portion of the market is betting against the stock's performance and could lead to increased volatility if short sellers continue to add to their positions.

SYK Forecast - Frequently Asked Questions

According to the research reports of 28 Wall Street equities research analysts, the average twelve-month stock price forecast for Stryker is $343.73, with a high forecast of $405.00 and a low forecast of $275.00.

28 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 7 hold ratings and 21 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SYK shares.

According to analysts, Stryker's stock has a predicted upside of 5.68% based on their 12-month stock forecasts.

Over the previous 90 days, Stryker's stock had 3 downgrades and 1 upgrade by analysts.

Analysts like Stryker more than other "healthcare" companies. The consensus rating for Stryker is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how SYK compares to other companies.


MarketBeat monitors more than a dozen sources for Stryker analyst ratings, with the most recent rating issued on 11/2/2026.
From Our Partners